SCHEMBL5753873

SCHEMBL5753873

O=C(Nc1cccs1)c1ccc[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.46
GAA P10253 6/20 0.45
HSD17B10 Q99714 4/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
RAB9A P51151 4/20 0.44
HTT P42858 4/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 2/20 0.43
GFER P55789 2/20 0.43
BCAT2 O15382 1/20 0.43
MAPT P10636 4/20 0.43
ALOX15 P16050 2/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ATM Q13315 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1864649 0.75 RAB9A (0.57) GAAMEN1KMT2ARAB9ALMNA
SCHEMBL3559655 0.75 MEN1 (0.60) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL10774714 0.75 KDM4E (0.42) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL27177336 0.74
SCHEMBL2656771 0.73 RAB9A (0.68) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL14394393 0.73 NPC1 (0.69) MEN1KMT2ARAB9AHTTLMNA
SCHEMBL3914463 0.72 NAMPT (0.63) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL9547640 0.72 GAA (0.72) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL28723721 0.72 GAA (0.58) GAAHSD17B10MEN1KMT2ARAB9A
SCHEMBL4954697 0.72 NPC1 (0.59) KCNMA1MEN1KMT2ARAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed